Non-reactive mydriasis after rocuronium infusion in patients with COVID-19: a case series

Braz J Anesthesiol. 2022 Nov-Dec;72(6):829-831. doi: 10.1016/j.bjane.2022.05.007. Epub 2022 Jun 8.
No abstract available

MeSH terms

  • Androstanols / adverse effects
  • COVID-19*
  • Humans
  • Mydriasis* / chemically induced
  • Neuromuscular Nondepolarizing Agents* / adverse effects
  • Rocuronium

Substances

  • Rocuronium
  • Neuromuscular Nondepolarizing Agents
  • Androstanols